AIM
CEMI

Acrospire Investment Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Acrospire Investment Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-58
Closed – – 2618
2016
Q3 		$0 Sell
58
-4,080
-99% -$29.4K ﹤0.01% 2359
2016
Q2 		$34K Buy
+4,138
New +$32.2K 0.03% 1320

Other funds holding CEMI

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NJBEST
New Jersey Better Educational Savings Trust Trenton, New Jersey $62.2M AUM 2.58% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrospire Investment Management's CEMI Position: Q4 2016 in Review

Acrospire Investment Management sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2016, closing a stake of 58 shares.

Acrospire Investment Management first reported a position in CEMI in Q2 2016 and held it in 2 quarters. The position peaked at $34K in Q2 2016. 26 funds tracked by Wall St. Rank hold CEMI as of Q4 2016.

  • Acrospire Investment Management reported no remaining Chembio diagnostics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 58 Chembio diagnostics, Inc. shares in Q4 2016.
  • Acrospire Investment Management first reported a position in Chembio diagnostics, Inc. in Q2 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Chembio diagnostics, Inc. position peaked at $34K in Q2 2016.
  • 26 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.